Sheela Sathyanarayana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sheela Sathyanarayana has a total of 340 co-authors. Here are the top co-authors by number of shared publications:
- Emily S. Barrett
Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, USA
13 shared publications - Shanna Helen Swan
Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA
13 shared publications - Catherine J. Karr
Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington, USA
10 shared publications - Nicole R. Bush
Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California San Francisco, San Francisco, CA, USA
9 shared publications - J. Bruce Redmon
Department of Medicine and Urologic Surgery, University Of Minnesota, Minneapolis, MN, USA
8 shared publications - Kaja Z. LeWinn
Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA 94107, USA
7 shared publications
Latest Publications
- Open Access
- 21 May 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 195 (8) , 2158-2169
Prenatal over-the-counter acetaminophen use and birth outcomes in the ECHO Cohort
Acetaminophen is among the most common over-the-counter medications used during pregnancy. Given inconsistent findings from both experimental and epidemiological studies on associations between use and adverse health outcomes, further research is warranted. To address this, our objective was to assess the relationship between prenatal acetaminophen use and birth outcomes. We studied 8957 mother–infant pairs from 36 pediatric study sites participating in the Environmental influences on Child Health Outcomes (ECHO) program. After imputation and inverse probability weighting, we used regression models to examine the relationship between acetaminophen during pregnancy and the following outcomes: (1) preterm birth, (2) birthweight, (3) small-for-gestational age (SGA), and (4) large-for-gestational-age (LGA). Approximately 59% of mothers reported using acetaminophen at any point during their pregnancy (n = 5257). After adjustment for relevant covariates, prenatal acetaminophen use was associated with lower odds of LGA (adjusted odds ratio [aOR]: 0.87; 95% CI: 0.79, 0.96). Prenatal acetaminophen use was not associated with preterm birth (aOR: 0.99; 95% CI: 0.86, 1.14), birthweight (aβ: −7.52 g; 95% CI: −27.80, 12.77) or SGA (aOR: 1.02; 95% CI: 0.88, 1.18). Based on these findings, future research should test for dose–response, trimester-specific exposures, and factors affecting individual responses.
- 21 May 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 195 (8) , 2158-2169
Open AccessPrenatal over-the-counter acetaminophen use and birth outcomes in the ECHO Cohort
Acetaminophen is among the most common over-the-counter medications used during pregnancy. Given inconsistent findings from both experimental and epidemiological studies on associations between use and adverse health outcomes, further research is warranted. To address this, our objective was to assess the relationship between prenatal acetaminophen use and birth outcomes. We studied 8957 mother–infant pairs from 36 pediatric study sites participating in the Environmental influences on Child Health Outcomes (ECHO) program. After imputation and inverse probability weighting, we used regression models to examine the relationship between acetaminophen during pregnancy and the following outcomes: (1) preterm birth, (2) birthweight, (3) small-for-gestational age (SGA), and (4) large-for-gestational-age (LGA). Approximately 59% of mothers reported using acetaminophen at any point during their pregnancy (n = 5257). After adjustment for relevant covariates, prenatal acetaminophen use was associated with lower odds of LGA (adjusted odds ratio [aOR]: 0.87; 95% CI: 0.79, 0.96). Prenatal acetaminophen use was not associated with preterm birth (aOR: 0.99; 95% CI: 0.86, 1.14), birthweight (aβ: −7.52 g; 95% CI: −27.80, 12.77) or SGA (aOR: 1.02; 95% CI: 0.88, 1.18). Based on these findings, future research should test for dose–response, trimester-specific exposures, and factors affecting individual responses.
- 7 April 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 195 (8) , 2131-2138
Maternal oxidative stress biomarkers across pregnancy in relation to fetal growth: evidence from the TIDES cohort
Oxidative stress (OS), an imbalance between reactive oxygen species and antioxidants, has been linked to impaired placental function and suboptimal fetal growth, yet trimester-specific associations remain poorly understood. We examined 561 mother–infant pairs from The Infant Development and Environmental Study, measuring maternal urinary biomarkers of DNA oxidation (8-hydroxydeoxyguanosine (8-OHdG)), lipid peroxidation (malondialdehyde (MDA) and F2-isoprostanes), and protein oxidation (dityrosine (diY)) at first and second trimesters. Using generalized linear models, we examined prospective associations between OS and ultrasound-derived growth velocities. Early pregnancy OS biomarkers were persistently associated with reduced second and third trimester growth velocities. First trimester lipid peroxidation markers (8-PGF2α, 15-PGF2α, and 8,15-PGF2α) were associated with slower estimated fetal weight (EFW) growth velocity in both second trimester (−0.81, −0.93, and −1.72 g/week per log-unit increase, respectively) and third trimester (−4.25, −5.60, and −6.74 g/week). Similarly, first trimester 8-OHdG and diY were associated with both second trimester (−1.31 and −1.17 g/week, respectively) and third trimester EFW velocity (−8.01 and −6.75 g/week, respectively). Second trimester 8-OHdG and MDA were associated with slower third trimester EFW velocity (−8.57 and −9.25 g/week, respectively). These results provide novel insights into trimester-specific associations between OS and fetal growth.
- 7 April 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 195 (8) , 2131-2138
Maternal oxidative stress biomarkers across pregnancy in relation to fetal growth: evidence from the TIDES cohort
Oxidative stress (OS), an imbalance between reactive oxygen species and antioxidants, has been linked to impaired placental function and suboptimal fetal growth, yet trimester-specific associations remain poorly understood. We examined 561 mother–infant pairs from The Infant Development and Environmental Study, measuring maternal urinary biomarkers of DNA oxidation (8-hydroxydeoxyguanosine (8-OHdG)), lipid peroxidation (malondialdehyde (MDA) and F2-isoprostanes), and protein oxidation (dityrosine (diY)) at first and second trimesters. Using generalized linear models, we examined prospective associations between OS and ultrasound-derived growth velocities. Early pregnancy OS biomarkers were persistently associated with reduced second and third trimester growth velocities. First trimester lipid peroxidation markers (8-PGF2α, 15-PGF2α, and 8,15-PGF2α) were associated with slower estimated fetal weight (EFW) growth velocity in both second trimester (−0.81, −0.93, and −1.72 g/week per log-unit increase, respectively) and third trimester (−4.25, −5.60, and −6.74 g/week). Similarly, first trimester 8-OHdG and diY were associated with both second trimester (−1.31 and −1.17 g/week, respectively) and third trimester EFW velocity (−8.01 and −6.75 g/week, respectively). Second trimester 8-OHdG and MDA were associated with slower third trimester EFW velocity (−8.57 and −9.25 g/week, respectively). These results provide novel insights into trimester-specific associations between OS and fetal growth.
- Open Access
- 25 October 2025
- Published by Elsevier in Environment International
- Vol. 205, 109883
Prenatal exposure to environmental phenolic compounds and their association with childhood atopic dermatitis, asthma, and allergic rhinitis in the ECHO cohort
- 25 October 2025
- Published by Elsevier in Environment International
- Vol. 205, 109883
Open AccessPrenatal exposure to environmental phenolic compounds and their association with childhood atopic dermatitis, asthma, and allergic rhinitis in the ECHO cohort
- Open Access
- 2 July 2025
- Published by Elsevier in Environment International
- Vol. 202, 109649
Prenatal exposure to organophosphate ester flame retardants and behavioral outcomes in early childhood in the Environmental influences on Child Health Outcomes (ECHO) cohort
- 2 July 2025
- Published by Elsevier in Environment International
- Vol. 202, 109649
Open AccessPrenatal exposure to organophosphate ester flame retardants and behavioral outcomes in early childhood in the Environmental influences on Child Health Outcomes (ECHO) cohort
- Open Access
- 2 July 2025
- Published by Elsevier in Environment International
- Vol. 202, 109647
Prenatal exposure to phthalates and alternative plasticizers and emotional and behavioral outcomes in early childhood in the Environmental influences on Child Health outcomes (ECHO) cohort
- 2 July 2025
- Published by Elsevier in Environment International
- Vol. 202, 109647
Open AccessPrenatal exposure to phthalates and alternative plasticizers and emotional and behavioral outcomes in early childhood in the Environmental influences on Child Health outcomes (ECHO) cohort
- 28 November 2024
- Published by Elsevier in Environmental Pollution
- Vol. 366, 125415
Prenatal exposure to environmental bisphenols over time and their association with childhood asthma, allergic rhinitis and atopic dermatitis in the ECHO consortium
- 28 November 2024
- Published by Elsevier in Environmental Pollution
- Vol. 366, 125415
Prenatal exposure to environmental bisphenols over time and their association with childhood asthma, allergic rhinitis and atopic dermatitis in the ECHO consortium
- Open Access
- 29 October 2024
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 8 (12) , bvae189
Associations of Phthalate Exposure With Adiposity and Metabolic Syndrome in US Adolescents and Adults, NHANES 2013 to 2018
Context: Phthalates are ubiquitous endocrine-disrupting chemicals and suspected obesogens. However, the associations with fat distribution and associated cardiometabolic complications remain unclear. Objective: We examined the associations between phthalate exposure, body fat (total and distribution patterns), and metabolic syndrome (MetS) among US adolescents and adults. Methods: We analyzed cross-sectional data from 829 adolescents and 3905 adults in the 2013 to 2018 National Health and Nutrition Examination Survey. Total percentage body fat (%BF), visceral adipose tissue (VAT) mass, and android to gynoid (A/G) ratio were determined using dual-energy x-ray absorptiometry. Associations between molar sums of low molecular weight (∑LMW), high molecular weight (∑HMW), and di(2-ethylhexyl) phthalate (∑DEHP) metabolites, and adiposity indicators and MetS were analyzed with multivariable linear and logistic regressions. Models included sex interaction terms, were stratified by age group, and adjusted for relevant covariates. Results: ∑HMW and ∑DEHP exposures were positively associated with %BF in males, and all phthalate groups were associated with greater VAT mass and A/G ratio in adolescent males. Five-fold increases in ∑HMW and ∑DEHP metabolites were associated with 21.7% (95% CI, 10.5-33.9) and 18.0% (95% CI, 7.72-29.2) greater VAT mass among adolescent males, respectively. Sex modified the relationship between ∑HMW exposure and A/G ratio among adolescents (interaction P value = .0185). Phthalates were not associated with odds of MetS. When assessing individual MetS components, phthalates were associated with hyperglycemia in adult males. Conclusion: Greater exposure to phthalates was associated with greater %BF in all males, and with fat distribution in adolescent males; however, phthalates were not linked to MetS.
- 29 October 2024
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 8 (12) , bvae189
Open AccessAssociations of Phthalate Exposure With Adiposity and Metabolic Syndrome in US Adolescents and Adults, NHANES 2013 to 2018
Context: Phthalates are ubiquitous endocrine-disrupting chemicals and suspected obesogens. However, the associations with fat distribution and associated cardiometabolic complications remain unclear. Objective: We examined the associations between phthalate exposure, body fat (total and distribution patterns), and metabolic syndrome (MetS) among US adolescents and adults. Methods: We analyzed cross-sectional data from 829 adolescents and 3905 adults in the 2013 to 2018 National Health and Nutrition Examination Survey. Total percentage body fat (%BF), visceral adipose tissue (VAT) mass, and android to gynoid (A/G) ratio were determined using dual-energy x-ray absorptiometry. Associations between molar sums of low molecular weight (∑LMW), high molecular weight (∑HMW), and di(2-ethylhexyl) phthalate (∑DEHP) metabolites, and adiposity indicators and MetS were analyzed with multivariable linear and logistic regressions. Models included sex interaction terms, were stratified by age group, and adjusted for relevant covariates. Results: ∑HMW and ∑DEHP exposures were positively associated with %BF in males, and all phthalate groups were associated with greater VAT mass and A/G ratio in adolescent males. Five-fold increases in ∑HMW and ∑DEHP metabolites were associated with 21.7% (95% CI, 10.5-33.9) and 18.0% (95% CI, 7.72-29.2) greater VAT mass among adolescent males, respectively. Sex modified the relationship between ∑HMW exposure and A/G ratio among adolescents (interaction P value = .0185). Phthalates were not associated with odds of MetS. When assessing individual MetS components, phthalates were associated with hyperglycemia in adult males. Conclusion: Greater exposure to phthalates was associated with greater %BF in all males, and with fat distribution in adolescent males; however, phthalates were not linked to MetS.
- Open Access
- 20 April 2024
- Published by Elsevier in Environment International
- Vol. 187, 108678
Urinary concentrations of phthalate metabolites in relation to preeclampsia and other hypertensive disorders of pregnancy in the environmental influences on child health outcomes (ECHO) program
- 20 April 2024
- Published by Elsevier in Environment International
- Vol. 187, 108678
Open AccessUrinary concentrations of phthalate metabolites in relation to preeclampsia and other hypertensive disorders of pregnancy in the environmental influences on child health outcomes (ECHO) program
- 28 March 2024
- Published by Elsevier in Environmental Research
- Vol. 252 (Pt 1) , 118789
Environmental exposure to melamine and its derivatives and kidney outcomes in children
- 28 March 2024
- Published by Elsevier in Environmental Research
- Vol. 252 (Pt 1) , 118789
Environmental exposure to melamine and its derivatives and kidney outcomes in children
- 1 January 2024
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 132 (1) , 11303
Invited Perspective: Prenatal PM2.5 Exposure Associated with Adverse Birth Outcomes Requiring Medical Interventions
- 1 January 2024
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 132 (1) , 11303
Invited Perspective: Prenatal PM2.5 Exposure Associated with Adverse Birth Outcomes Requiring Medical Interventions